D-penicillamine for primary biliary cirrhosis.
作者信息
James O F
出版信息
Gut. 1985 Feb;26(2):109-13. doi: 10.1136/gut.26.2.109.
Abstract
摘要
相似文献
1
D-penicillamine for primary biliary cirrhosis.
Gut. 1985 Feb;26(2):109-13. doi: 10.1136/gut.26.2.109.
2
Double blind controlled trial of d-penicillamine in patients with primary biliary cirrhosis.
Gut. 1985 Feb;26(2):114-9. doi: 10.1136/gut.26.2.114.
3
Trial of penicillamine in advanced primary biliary cirrhosis.
N Engl J Med. 1985 Apr 18;312(16):1011-5. doi: 10.1056/NEJM198504183121602.
4
Primary biliary cirrhosis and lichen planus.
J Am Acad Dermatol. 1983 Oct;9(4):540-5. doi: 10.1016/s0190-9622(83)70166-0.
5
Penicillamine therapy 'encouraging' in primary biliary cirrhosis study.
JAMA. 1982 Jul 2;248(1):11-2.
6
Asymptomatic primary biliary cirrhosis. Presentation, histology, and results with D-penicillamine.
Mayo Clin Proc. 1978 Sep;53(9):587-93.
7
Systematic review and meta-analysis: D-Penicillamine vs. placebo/no intervention in patients with primary biliary cirrhosis--Cochrane Hepato-Biliary Group.
Aliment Pharmacol Ther. 2006 Dec;24(11-12):1535-44. doi: 10.1111/j.1365-2036.2006.03164.x.
8
A prospective trial of D-penicillamine in primary biliary cirrhosis.
N Engl J Med. 1982 Feb 11;306(6):319-26. doi: 10.1056/NEJM198202113060602.
9
A prospective clinical trial of D-penicillamine in the treatment of primary biliary cirrhosis.
Hepatology. 1985 Nov-Dec;5(6):1139-42. doi: 10.1002/hep.1840050613.
10
D-penicillamine treatment improves survival in primary biliary cirrhosis.
Lancet. 1981 Jun 13;1(8233):1275-7. doi: 10.1016/s0140-6736(81)92456-9.
引用本文的文献
1
Skin Manifestations Associated with Autoimmune Liver Diseases: a Systematic Review.
Clin Rev Allergy Immunol. 2017 Dec;53(3):394-412. doi: 10.1007/s12016-017-8649-9.
2
Evaluation of the Chinese Medicinal Herb, Graptopetalum paraguayense, as a Therapeutic Treatment for Liver Damage in Rat Models.
Evid Based Complement Alternat Med. 2012;2012:256561. doi: 10.1155/2012/256561. Epub 2012 Jul 2.
3
[Primary biliary liver cirrhosis and overlap syndrome. Diagnosis and therapy].
Internist (Berl). 2004 Jan;45(1):16-26. doi: 10.1007/s00108-003-1127-x.
4
Treatment in primary biliary cirrhosis.
Br Med J (Clin Res Ed). 1987 Oct 10;295(6603):867-8. doi: 10.1136/bmj.295.6603.867.
5
Primary biliary cirrhosis.
Gut. 1991 Sep;Suppl(Suppl):S73-8. doi: 10.1136/gut.32.suppl.s73.
本文引用的文献
1
Treatment of Wilson's disease with penicillamine.
Lancet. 1960 Jan 23;1(7117):188-92. doi: 10.1016/s0140-6736(60)90109-4.
2
Is copper hepatotoxic in primary biliary cirrhosis?
J Clin Pathol. 1981 Oct;34(10):1071-5. doi: 10.1136/jcp.34.10.1071.
3
A prospective trial of D-penicillamine in primary biliary cirrhosis.
N Engl J Med. 1982 Feb 11;306(6):319-26. doi: 10.1056/NEJM198202113060602.
4
The prognostic importance of clinical and histologic features in asymptomatic and symptomatic primary biliary cirrhosis.
N Engl J Med. 1983 Jan 6;308(1):1-7. doi: 10.1056/NEJM198301063080101.
5
Low therapeutic value of D-penicillamine in a short-term prospective trial in primary biliary cirrhosis.
Liver. 1983 Dec;3(6):345-52. doi: 10.1111/j.1600-0676.1983.tb00887.x.
6
Evidence against an immune complex pathogenesis of primary biliary cirrhosis.
Gastroenterology. 1982 Sep;83(3):677-83.
7
Primary biliary cirrhosis--a revised clinical spectrum.
Lancet. 1981 Jun 13;1(8233):1278-81. doi: 10.1016/s0140-6736(81)92457-0.
8
D-penicillamine treatment improves survival in primary biliary cirrhosis.
Lancet. 1981 Jun 13;1(8233):1275-7. doi: 10.1016/s0140-6736(81)92456-9.
9
A defect in the intramolecular and intermolecular cross-linking of collagen caused by penicillamine. II. Functional groups involved in the interaction process.
J Biol Chem. 1969 Apr 10;244(7):1787-95.
10
The presentation and diagnosis of 100 patients with primary biliary cirrhosis.
N Engl J Med. 1973 Sep 27;289(13):674-8. doi: 10.1056/NEJM197309272891306.
Zotero 插件